Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

KOSDAQ/950160 stock hub

KOSDAQ/950160 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

KOSDAQ/950160is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
10.8T
KOSDAQ
Market data

Live price

Current market quote for this ticker.

Current price
KOSDAQ/950160
In the news

Latest news · KOSDAQ/950160

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 9.8P50 17.1P75 31.9
Trailing P/En/a
P25 12P50 23.1P75 39.5
ROE-183.4
P25 -17.1P50 0.7P75 8.5
ROIC-9.1
P25 -9P50 1.3P75 6.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All KOSDAQ/950160 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
168
Groups with data
11
Currency
KRW
Showing 168 of 168 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
KR
Employees
29
Enterprise value
KRW 10.8T
Exchange
KOSDAQ
Financial currency
KRW
First seen
2026-05-10
Industry
Biotechnology
Isin
KR8840120008
Last refreshed
2026-05-10
Market cap
KRW 10.8T
Price
KRW 127,800
Price currency
KRW
Rev Per Employee
177,886,379.31x
Sector
Healthcare
Sic
2836
Symbol
kosdaq/950160
Website
https://www.tissuegene.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

6
MetricValue
Earnings Yield
-1.78%
EV Earnings
-56.22x
EV/FCF
-429.46x
FCF yield
-0.23%
P/B ratio
168.99x
P/S ratio
2,099.22x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

16
MetricValue
Gross margin
11.91%
Gross Profit
KRW 614.5M
Gross Profit Growth
12.72%
Gross Profit Growth Q
-20.36%
Gross Profit Growth3 Y
-56.84%
Gross Profit Growth5 Y
13.52%
Net Income
KRW -192.6B
Net Income Growth Years
0%
Pretax Margin
-3,732.85%
Profit Per Employee
KRW -6.6B
ROA
-4.32
Roa5y
-15.65
ROCE
-32.68
ROE
-183.4
Roe5y
-70.47
ROIC
-9.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

9
MetricValue
Cagr1y
243.84%
Cagr3y
128.54%
EPS Growth Years
0
Revenue Growth
1.68x
Revenue Growth Q
10.5x
Revenue Growth Quarters
1x
Revenue Growth Years
2x
Revenue Growth3 Y
-18.29x
Revenue Growth5 Y
7.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
KRW 0.02
Assets
KRW 424B
Cash
KRW 82.1B
Current Assets
KRW 86.3B
Current Liabilities
KRW 355.7B
Debt
KRW 79.6B
Debt Equity
KRW 1.24
Debt FCF
KRW -3.16
Equity
KRW 64.1B
Interest Coverage
-249.1
Liabilities
KRW 359.9B
Long Term Assets
KRW 337.7B
Long Term Liabilities
KRW 4.2B
Net Cash
KRW 2.5B
Net Cash By Market Cap
KRW 0.02
Net Debt Equity
KRW -0.04
Tangible Book Value
KRW 63.9B
Tangible Book Value Per Share
KRW 768
WACC
1.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.24
Inventory Turnover
59.04
Net Working Capital
KRW -276.1B
Quick ratio
0.23
Working Capital
KRW -269.4B
Working Capital Turnover
KRW -0.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-6.78%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
243.55%
200-day SMA
70,615.5
3Y total return
1,094.39%
50-day SMA
103,688
50-day SMA vs 200-day SMA
50over200
All Time High
138,000
All Time High Change
-7.39%
All Time High Date
2026-05-08
All Time Low
7,710
All Time Low Change
1,557.59%
All Time Low Date
2023-10-27
ATR
9,393.8
Beta
-0.55
Beta1y
0.29
Beta2y
0.17
Ch YTD
60.55
High
138,000
High52
138,000
High52 Date
2026-05-08
High52ch
-7.39%
Low
114,900
Low52
31,250
Low52 Date
2025-05-14
Low52ch
308.96%
Ma50ch
23.25%
Price vs 200-day SMA
80.98%
RSI
68.93
RSI Monthly
84.17
RSI Weekly
64.99
Sharpe ratio
1.61x
Sortino ratio
3.08
Total Return
-6.78%
Tr YTD
60.55
Tr1m
29.35%
Tr1w
21.95%
Tr3m
35.53%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
KRW -22.3B
Operating margin
-432.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
17,947,993%
Net Borrowing
178,595,662,000
Shares Insiders
17.99%
Shares Institutions
0.54%
Shares Out
84,736,050
Shares Qo Q
2.13%
Shares Yo Y
6.78%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

48
MetricValue
Adjusted FCF
KRW -25.3B
Average Volume
500,275.45x
Bv Per Share
770
CAPEX
KRW -1.2B
Ch1m
29.35
Ch1w
21.95
Ch1y
243.5
Ch3m
35.53
Ch3y
1,094.4
Ch6m
188.8
Change
11.52%
Change From Open
11.23
Close
114,600
Days Gap
0.26
Depreciation Amortization
784,020,000
Dollar Volume
219,183,645,600
EBIT
KRW -22.3B
EBITDA
KRW -21.5B
EPS
KRW -2,344
F Score
3
FCF
KRW -25.2B
FCF EV Yield
-0.23x
FCF Per Share
KRW -298
Financing CF
222,058,355,000
Fiscal Year End
December
Founded
1,999
Income Tax
KRW 20.9M
Investing CF
-131,648,703,000
Is Primary Listing
1
Last Report Date
2025-12-31
Ma150
80,549.3
Ma150ch
58.66%
Ma20
104,620
Ma20ch
22.16%
Net CF
66,366,821,000
Open
114,900
Position In Range
55.84
Ppne
6,121,865,000
Price Date
2026-05-08
Ptbv Ratio
169.5
Relative Volume
3.59x
Revenue
5,158,705,000x
SBC By Revenue
2.19x
Share Based Comp
112,728,000
Tax By Revenue
0.41x
Tr6m
188.81%
Volume
1,715,052
Z Score
3.18
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does KOSDAQ/950160 pay a dividend?

Capital-return profile for this ticker.

Performance

KOSDAQ/950160 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+243.5%
S&P 500 1Y: n/a
3Y total return
+1094.4%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns KOSDAQ/950160?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.5%
Share of float held by funds and institutions
Insider ownership
+18.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+6.8%
Negative means the company is buying back shares.
Technical

KOSDAQ/950160 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
68.9
Neutral momentum band
Price vs 200-day MA
+81.0%
50/200-day relationship not available
Beta (5Y)
-0.55
Less volatile than the market
Sharpe ratio
1.61
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About KOSDAQ/950160

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/950160 stock rating?

kosdaq/950160 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/950160 analysis?

The full report lives at /stocks/kosdaq/950160/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/950160?

The latest report frames kosdaq/950160 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/950160 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.